The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Infections, Inflammation, and the Risk of Coronary Heart Disease
Open accessAbstract
Background —The role of infections and inflammation in the pathophysiology of coronary heart disease is emerging. We studied the independent and joint effects of these 2 components on coronary risk. Methods and Results —We measured baseline levels of C-reactive protein (CRP) and antibodies to adenovirus, enterovirus, cytomegalovirus, and herpes simplex virus as well as to Chlamydia pneumoniae ( Cpn ) and Helicobacter pylori in 241 subjects who suffered either myocardial infarction or coronary death during the 8.5-year trial in the Helsinki Heart Study, a coronary primary prevention trial. The 241 controls in this nested case-control study were subjects who completed the study without coronary events. Antibody levels to herpes simplex type I (HSV-1) and to Cpn were higher in cases than in controls, whereas the distributions of antibodies to other infectious agents were similar. Mean CRP was higher in cases (4.4 versus 2.0 mg/L; P <0.001), and high CRP increased the risks associated with smoking and with high antimicrobial antibody levels. The odds ratios in subjects with high antibody and high CRP levels were 25.4 (95% CI 2.9–220.3) for HSV-1 and 5.4 (95% CI 2.4–12.4) for Cpn compared with subjects with low antibody levels and low CRP. High antibody levels to either HSV-1 or to Cpn increased the risk independently of the other, and their joint effect was close to additive. Conclusions —Two chronic infections, HSV-1 and Cpn , increase the risk of coronary heart disease. The effect is emphasized in subjects with ongoing inflammation, denoted by increased CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Self-citationThe Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Self-citationThompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Chronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Jf, W. (1980) · PubMed Central · Cited by 799
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Self-citationDemonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries
Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 762
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Libby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Ramirez, J. A., & Chlamydia pneumoniae/Atherosclerosis Study Group* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00008 · Cited by 478
Zhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X., Finkel, T., & Epstein, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350903 · Cited by 451
Hyöty, H., Hiltunen, M., Knip, M., Laakkonen, M., Vähäsalo, P., Karjalainen, J., Koskela, P., Roivainen, M., Leinikki, P., Hovi, T., et al. (1995) · Diabetes · doi:10.2337/diab.44.6.652 · Cited by 419
Self-citationCYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS
MELNICK, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92529-1 · Cited by 331
Viruses in the etiology of atherosclerosis.
Benditt, E. P., Barrett, T., & McDougall, J. K. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.20.6386 · Cited by 326
Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke
Mattila, K. J., Valtonen, V. V., Nieminen, M. S., & Asikainen, S. (1998) · Clinical Infectious Diseases · doi:10.1086/514570 · Cited by 309
Linnanmäki, E., Leinonen, M., Mattila, K., Nieminen, M. S., Valtonen, V, & Saikku, P. (1993) · Circulation · doi:10.1161/01.cir.87.4.1130 · Cited by 283
Self-citationAssociation of virulent Helicobacter pylori strains with ischemic heart disease
(1999) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(99)90189-1 · Cited by 268
Blasi, F., Denti, F., Erba, M., Cosentini, R., Raccanelli, R., Rinaldi, A., Fagetti, L., Esposito, G., Ruberti, U., & Allegra, L. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.11.2766-2769.1996 · Cited by 250
Ong, G., Thomas, B. J., Mansfield, A. O., Davidson, B. R., & Taylor-Robinson, D. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.2.102 · Cited by 210
Ridker, P. M., Hennekens, C. H., Stampfer, M. J., & Wang, F. (1998) · Circulation · doi:10.1161/01.cir.98.25.2796 · Cited by 185
Infections and Atherosclerosis: New Clues from an Old Hypothesis?
Nieto, F. J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009570 · Cited by 182
An Epidemic of Infections Due to Chlamydia pneumoniae in Military Conscripts
Ekman, M.-R., Grayston, J. T., Visakorpi, R., Kleemola, M., Kuo, C.-C., & Saikku, P. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.420 · Cited by 179
Self-citationRaised C-reactive protein levels in serum from smokers
Das, I. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90133-0 · Cited by 149
Inflammation, Infection, and Cardiovascular Risk: How Good Is the Clinical Evidence?
Ridker, P. M. (1998) · Circulation · doi:10.1161/01.cir.97.17.1671 · Cited by 144
Blum, A., Giladi, M., Weinberg, M., Kaplan, G., Pasternack, H., Laniado, S., & Miller, H. I. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00019-8 · Cited by 127
Györkey, F., Melnick, J. L., GUINN, G. A., Györkey, P., & DeBakey, M. E. (1984) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(84)90050-9 · Cited by 120
COXSACKIE VIRUS INFECTION IN ACUTE MYOCARDIAL INFARCTION
Nicholls, A. C., & Thomas, M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91203-x · Cited by 79
Enterovirus Infections as a Possible Risk Factor for Myocardial Infarction
Roivainen, M., Alfthan, G., Jousilahti, P., Kimpimäki, M., Hovi, T., & Tuomilehto, J. O. (1998) · Circulation · doi:10.1161/01.cir.98.23.2534 · Cited by 73
Self-citationCOXSACKIE B VIRUS INFECTIONS AND MYOCARDIAL INFARCTION
Griffiths, P. D., Hannington, G., & Booth, J. C. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92655-0 · Cited by 61
Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link?
Nieto, F. J., Sorlie, P. D., Comstock, G. W., Wu, K. K., Adam, E., Melnick, J. L., & Szklo, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1780 · Cited by 50
Ultrastructural changes in cardiac capillaries of Coxsackie virus B4-infected mice.
Sohal, R. S., Burch, G. E., Chu, K., Leiderman, E. A., & Colcolough, H. L. (1968) · PubMed · Cited by 46
Coxsackie B Virus Antibodies in Myocardial Infarction
NIKOSKELAINEN, J., Kalliomäki, J. L., LAPINLEIMU, K., et al. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb08566.x · Cited by 40
The Helsinki Heart Study: coronary heart disease incidence during an extended follow‐up
Heinonen, O. P., Huttunen, J. K., Manninen, V., Mänttäri, M., Koskinen, P., Tenkanen, L., & Frick, M. H. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01030.x · Cited by 38
Self-citationPesonen, E. J. (1974) · Atherosclerosis · doi:10.1016/0021-9150(74)90003-3 · Cited by 35
Cited by
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Metadata
- Authors
- Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivanen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., & Mänttäri, M.
- Venue
- Circulation
- Published
- 2000-01-25
- Volume
- 101
- Issue
- 3
- Pages
- 252-257
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2121308654
- Cited by
- 347
- References
- 40
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.